Clinical Trial

Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic Factor

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated February 7, 2024 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to investigate the effect of coenzyme Q10 supplementation (150 mg/b.i.d, 300 mg/d, 12 weeks) on coenzyme Q10, glucose parameters, BDNF, myokines, and cognitive function in mild cognitive impairment (MCI) and Alzheimer's disease (AD) patients who combined with hyperglycemia but without sarcopenia, or with hyperglycemia and pre-sarcopenia.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06040905
Lead Sponsor Chung Shan Medical University
Collaborators: National Science and Technology Council
Conditions Mild Cognitive Impairment, Alzheimer Disease, Hyperglycemia, Pre-sarcopenia
Enrollment 100 participants
Start Date 2023-12-26
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-07